Samuel R Friedman1, Brooke S West2, Barbara Tempalski2, Cory M Morton2, Charles M Cleland3, Don C Des Jarlais4, H Irene Hall5, Hannah L F Cooper6. 1. Institute of Infectious Disease Research, National Development and Research Institutes, Inc., New York, NY; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD. Electronic address: friedman@ndri.org. 2. Institute of Infectious Disease Research, National Development and Research Institutes, Inc., New York, NY. 3. College of Nursing, New York University, New York, NY. 4. Beth Israel Medical Center, New York, NY. 5. Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA. 6. Behavioral Sciences and Health Education, Rollins School of Public Health at Emory University, Atlanta, GA.
Abstract
PURPOSE: We focus on a little-researched issue-how human immunodeficiency virus (HIV) epidemics and programs in key populations in metropolitan areas affect epidemics in other key populations. We consider (1) How are earlier epidemics among people who inject drugs (PWID) and men who have sex with men (MSM) related to later AIDS incidence and mortality among heterosexuals?; (2) Were prevention programs targeting PWID or MSM associated with lower AIDS incidence and mortality among heterosexuals?; and (3) Was the size of the potential bridge population of noninjecting drug users (NIDUs) in a metropolitan area associated with later AIDS incidence and mortality among heterosexuals? METHODS: Using data for 96 large U.S. metropolitan areas, Poisson regression assessed associations of population prevalences of HIV-infected PWID and MSM (1992); NIDU population prevalence (1992-1994); drug use treatment coverage for PWID (1993); HIV counseling and testing coverage for MSM and for PWID (1992); and syringe exchange presence (2000) with CDC data on AIDS incidence and mortality among heterosexuals in 2006-2008, with appropriate socioeconomic controls. RESULTS: Population density of HIV+ PWID and of NIDUs were positively related, and prevention programs for PWID negatively related to later AIDS incidence among heterosexuals and later mortality among heterosexuals living with AIDS. HIV+ MSM population density and prevention programs for MSM were not associated with these outcomes. CONCLUSIONS: Efforts to reduce HIV transmission among PWID and NIDUs may reduce AIDS and AIDS-related mortality among heterosexuals. More research is needed at metropolitan area, network, and individual levels into HIV bridging across key populations and how interventions in one key population affect HIV epidemics in other key populations.
PURPOSE: We focus on a little-researched issue-how human immunodeficiency virus (HIV) epidemics and programs in key populations in metropolitan areas affect epidemics in other key populations. We consider (1) How are earlier epidemics among people who inject drugs (PWID) and men who have sex with men (MSM) related to later AIDS incidence and mortality among heterosexuals?; (2) Were prevention programs targeting PWID or MSM associated with lower AIDS incidence and mortality among heterosexuals?; and (3) Was the size of the potential bridge population of noninjecting drug users (NIDUs) in a metropolitan area associated with later AIDS incidence and mortality among heterosexuals? METHODS: Using data for 96 large U.S. metropolitan areas, Poisson regression assessed associations of population prevalences of HIV-infected PWID and MSM (1992); NIDU population prevalence (1992-1994); drug use treatment coverage for PWID (1993); HIV counseling and testing coverage for MSM and for PWID (1992); and syringe exchange presence (2000) with CDC data on AIDS incidence and mortality among heterosexuals in 2006-2008, with appropriate socioeconomic controls. RESULTS: Population density of HIV+ PWID and of NIDUs were positively related, and prevention programs for PWID negatively related to later AIDS incidence among heterosexuals and later mortality among heterosexuals living with AIDS. HIV+ MSM population density and prevention programs for MSM were not associated with these outcomes. CONCLUSIONS: Efforts to reduce HIV transmission among PWID and NIDUs may reduce AIDS and AIDS-related mortality among heterosexuals. More research is needed at metropolitan area, network, and individual levels into HIV bridging across key populations and how interventions in one key population affect HIV epidemics in other key populations.
Authors: Enrique R Pouget; Samuel R Friedman; Charles M Cleland; Barbara Tempalski; Hannah L F Cooper Journal: J Urban Health Date: 2012-06 Impact factor: 3.671
Authors: Katie B Biello; Trace Kershaw; Robert Nelson; Matthew Hogben; Jeannette Ickovics; Linda Niccolai Journal: Am J Public Health Date: 2012-05-17 Impact factor: 9.308
Authors: Gregorio A Millett; John L Peterson; Stephen A Flores; Trevor A Hart; William L Jeffries; Patrick A Wilson; Sean B Rourke; Charles M Heilig; Jonathan Elford; Kevin A Fenton; Robert S Remis Journal: Lancet Date: 2012-07-20 Impact factor: 79.321
Authors: Harriet L Mills; Edward White; Caroline Colijn; Peter Vickerman; Robert Heimer Journal: Drug Alcohol Depend Date: 2013-05-18 Impact factor: 4.492
Authors: Sarah Polk; Jonathan M Ellen; Caroline Fichtenberg; Steven Huettner; Jacky M Jennings Journal: J Urban Health Date: 2013-08 Impact factor: 3.671
Authors: Samuel R Friedman; Brooke S West; Enrique R Pouget; H Irene Hall; Jennifer Cantrell; Barbara Tempalski; Sudip Chatterjee; Xiaohong Hu; Hannah L F Cooper; Sandro Galea; Don C Des Jarlais Journal: PLoS One Date: 2013-02-21 Impact factor: 3.240
Authors: Barbara Tempalski; Enrique R Pouget; Charles M Cleland; Joanne E Brady; Hannah L F Cooper; H Irene Hall; Amy Lansky; Brooke S West; Samuel R Friedman Journal: PLoS One Date: 2013-06-05 Impact factor: 3.240
Authors: Umedjon Ibragimov; Stephanie Beane; Adaora A Adimora; Samuel R Friedman; Leslie Williams; Barbara Tempalski; Ron Stall; Gina Wingood; H Irene Hall; Anna Satcher Johnson; Hannah L F Cooper Journal: J Urban Health Date: 2019-12 Impact factor: 3.671
Authors: Sherry Deren; Camila Gelpí-Acosta; Carmen E Albizu-García; Ángel González; Don C Des Jarlais; Salvador Santiago-Negrón Journal: Am J Public Health Date: 2014-09-11 Impact factor: 9.308
Authors: Angelos Hatzakis; Vana Sypsa; Dimitrios Paraskevis; Georgios Nikolopoulos; Chrissa Tsiara; Katerina Micha; Anastasios Panopoulos; Meni Malliori; Mina Psichogiou; Anastasia Pharris; Lucas Wiessing; Marita van de Laar; Martin Donoghoe; Douglas D Heckathorn; Samuel R Friedman; Don C Des Jarlais Journal: Addiction Date: 2015-07-14 Impact factor: 6.526
Authors: Umedjon Ibragimov; Stephanie Beane; Samuel R Friedman; Barbara Tempalski; Leslie D Williams; Sarah McKetta; Adaora A Adimora; Gina M Wingood; Ron D Stall; H Irene Hall; Anna Satcher Johnson; Hannah L F Cooper Journal: Ann Epidemiol Date: 2020-10-14 Impact factor: 3.797
Authors: Georgios K Nikolopoulos; Anastasios Fotiou; Eleftheria Kanavou; Clive Richardson; Marios Detsis; Anastasia Pharris; Jonathan E Suk; Jan C Semenza; Claudia Costa-Storti; Dimitrios Paraskevis; Vana Sypsa; Melpomeni-Minerva Malliori; Samuel R Friedman; Angelos Hatzakis Journal: PLoS One Date: 2015-04-15 Impact factor: 3.240
Authors: David H Cloud; Stephanie Beane; Adaora Adimora; Samuel R Friedman; Kevin Jefferson; H Irene Hall; Mark Hatzenbuehler; Anna Satcher Johnson; Ron Stall; Barbara Tempalski; Gina M Wingood; Akilah Wise; Kelli Komro; Hannah L F Cooper Journal: SSM Popul Health Date: 2018-11-28
Authors: Umedjon Ibragimov; Stephanie Beane; Samuel R Friedman; Kelli Komro; Adaora A Adimora; Jessie K Edwards; Leslie D Williams; Barbara Tempalski; Melvin D Livingston; Ronald D Stall; Gina M Wingood; Hannah L F Cooper Journal: PLoS One Date: 2019-10-09 Impact factor: 3.240
Authors: Barbara Tempalski; Leslie D Williams; Brooke S West; Hannah L F Cooper; Stephanie Beane; Umedjon Ibragimov; Samuel R Friedman Journal: Subst Abuse Treat Prev Policy Date: 2020-01-09